Crystal structure of SARS-CoV-2 antibody P2C-1F11 with mutated RBD

N-acetyl-beta-D-glucosamine; 2-acetamido-2-deoxy-beta-D-glucose; 2-acetamido-2-deoxy-D-glucose; 2-acetamido-2-deoxy-glucose; N-ACETYL-D-GLUCOSAMINE

Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.

Severe acute respiratory syndrome coronavirus 2

0.2M Ammonium sulfate, 0.1M Tris pH 8.5, 12%w/v PEG 8000

SARS-CoV-2 spike, receptor binding domain, antibody, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM complex